“A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Guselkumab at 52 weeks for the Treatment of Psoriatic Arthritis”, J of Skin, vol. 8, no. 1, p. s312, Jan. 2024, doi: 10.25251/skin.8.supp.312.